NVIDIA’s fiscal year 2025 revenue is projected to soar to $110 billion, according to a report by William Blair. The investment firm highlighted NVIDIA’s expanding market, which now spans $2.4 trillion, driven by growing demand in the semiconductor and cloud sectors.
William Blair Forecasts NVIDIA’s FY 2025 Revenue to Hit $110 Billion, Driven by Expanding TAM
In recent discussions, there has been a focus on NVIDIA's margins, with some market skeptics interpreting the company's current plateau—driven by the ongoing ramp-up of Blackwell production—as evidence of a downturn. Nevertheless, a more thorough analysis of NVIDIA's market position indicates that the bullish case for the stock remains robust. William Blair, an investment firm, issued a favorable assessment of NVIDIA's prospects on September 18, emphasizing the company's ongoing resilience.
William Blair emphasizes that NVIDIA has effectively broadened its Total Addressable Market (TAM) beyond the GPU sector, previously valued at approximately $100 billion, to encompass the broader semiconductor and cloud markets. NVIDIA's total potential market is $2.4 trillion, with TAMs of $800 billion and $1.6 trillion in these larger sectors, respectively.
William Blair anticipates that NVIDIA's revenue in fiscal year 2025 will reach an astonishing $110 billion, a substantial increase from the $15 billion recorded in fiscal year 2023, further emphasizing this growth potential.
The NVIDIA B100 AI accelerator is priced between $30,000 and $35,000, while the GB200 CPU+GPU combination is priced between $60,000 and $70,000 as the company's high-end products. Additionally, NVIDIA provides a 72-chip AI rack at a price point of $2 million to $3 million, which indicates the substantial demand for its AI computing solutions.
Oracle’s Petascale Supercluster and NVIDIA’s AI Solutions Signal Strong Demand for Accelerated Computing
Oracle's recent announcement of a "petascale" supercluster, which can accommodate up to 131,072 Blackwell GPUs, illustrates this demand. When combined with NVIDIA Quantum-2 InfiniBand networking and NVIDIA ConnectX-7 NICs, this supercluster can provide the cloud with 2.4 zettaflops of peak AI compute capacity.
NVIDIA CEO Jensen Huang underscored at the most recent Goldman Sachs Communacopia + Technology conference that accelerated computing is the company's "least risky market opportunity" in light of the current constraints on semiconductor design. According to Wccftech, this posture implies that NVIDIA is well-prepared to withstand any potential fluctuations in demand driven by AI.
The stock has increased by 137 percent year-to-date despite a minor dip of approximately 1 percent in NVIDIA shares before the Federal Reserve's interest rate decision. This increase indicates the company's ongoing confidence in its long-term growth potential.


Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Google Secures Pentagon AI Deal for Classified Projects
FBI Warns of China’s Expanding Hack-for-Hire Network Amid Extradition Case
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



